Mmicrophthalmia with Facial Clefting

Microphthalmia means a baby is born with one or both eyes that are abnormally small because eye development was interrupted before birth. It exists on a spectrum with anophthalmia (when an eye does not form at all), and it may occur alone or together with other eye changes like coloboma (a gap in eye structures). When microphthalmia happens together with a facial cleft, such as a cleft lip, cleft palate, or a rarer oblique craniofacial cleft, doctors may describe it as “microphthalmia with facial clefting.” Both features arise during early embryo development when the face and eyes are forming from nearby tissues; if those tissues do not grow, fuse, or signal to each other properly, both the face and the eye can be affected. PMC+2MedlinePlus+2

Microphthalmia means one or both eyes are smaller than usual because the eye did not fully develop before birth. Anophthalmia means the eye did not form at all. Both belong to the same “A/M spectrum.” Facial clefting means there is a split in the upper lip and/or the palate (roof of the mouth) because the tissues did not join in early pregnancy. When these happen together, doctors think about shared early-embryo pathways (genes and signals that shape the eye and face at the same time) or shared exposures in pregnancy (for example, medicines like high-dose retinoids) that can affect both organs. The condition can be isolated or part of a syndrome. Management focuses on protecting any vision, growing the eye socket and face properly, safe feeding and speech, and staged craniofacial surgery. Genetic testing helps look for a cause and guide counseling. MedlinePlus+2Nature+2

In practice, many children with microphthalmia have a small-appearing eye socket, small or absent eyeball, poor red reflex, nystagmus (shaky eyes), or very reduced vision. Facial clefting may be the familiar cleft lip and/or palate or, less commonly, oblique clefts that run between the lip, nose, and the inner corner of the eye (often called Tessier clefts in surgical classification). PMC+2Radiopaedia+2

Because the same developmental programs pattern the brain, face, and eyes, microphthalmia with facial clefting can be isolated or part of a genetic syndrome. Some well-known gene changes (for example SOX2 or OTX2) and some rare craniofacial disorders (for example ALX1-related frontonasal dysplasia) can present with a combination of small eyes and facial clefts. NCBI+2PMC+2

Other names

You may see these terms in reports or articles:

• Anophthalmia–microphthalmia (A/M) spectrum – the umbrella group that includes small or absent eyes, sometimes with coloboma. PMC

• MAC spectrum – short for Microphthalmia–Anophthalmia–Coloboma. gene.vision

• SOX2 disorder / SOX2 anophthalmia syndrome – a genetic diagnosis that often includes A/M and other features. NCBI+1

• OTX2-related microphthalmia – another genetic cause. PMC

• ALX1-related frontonasal dysplasia – can include extreme microphthalmia with severe facial clefting. PMC

• Tessier facial clefts – the surgical classification (numbers 0–14) used to name rare facial clefts by location; Tessier #3 and #4 often track between the lip/nose and the medial orbit (eye corner). Radiopaedia+1

Types

By eye involvement

1. Unilateral vs. bilateral microphthalmia (one eye vs both). Vision and cosmetic impact differ. JAMA Network

2. Simple microphthalmia (small eye but otherwise formed) vs complex microphthalmia (small eye with internal structural defects like coloboma, cataract, persistent fetal vasculature). PMC

3. Anophthalmia at the severe end of the spectrum (sometimes some microscopic eye tissue is present even when the eyeball looks absent). MedlinePlus

By facial cleft pattern

1. Cleft lip with or without cleft palate (common type). CDC

2. Isolated cleft palate (harder to see on prenatal ultrasound). Mayo Clinic

3. Oblique/Tessier craniofacial clefts involving the lip, nose, and orbit (rare; numbers 3–4 and adjacent numbers). Radiopaedia+1

By context

1. Isolated (only the eyes/face affected). Orpha

2. Syndromic (part of a bigger genetic picture such as SOX2, OTX2, BCOR/Lenz, MLS, CHARGE/CHD7, TFAP2A/branchio-oculo-facial, ALX1/frontonasal dysplasia). PMC+4NCBI+4PMC+4

Causes

Microphthalmia with facial clefting has many possible causes. Often there is no single “fault”—genes and environment both play a role. Below are 20 well-supported causes or contributing factors; children may have one or several of these.

1. SOX2 gene variants (dominant, often new in the child). SOX2 is a master regulator for early eye and brain development; changes commonly cause anophthalmia/microphthalmia, sometimes with other organ differences that bring added facial or airway challenges. NCBI+1

2. OTX2 gene variants. OTX2 is one of the top causes of A/M after SOX2; some individuals also have pituitary hormone issues, which can affect midline facial development. PMC+1

3. ALX1 (frontonasal dysplasia). Recessive ALX1 disruption causes extreme microphthalmia and severe facial clefting, directly linking both features. PMC

4. BCOR gene disorders. Lenz microphthalmia and oculo-facio-cardio-dental syndromes involve BCOR; Lenz may include cleft palate and other anomalies. PubMed+1

5. STR A6 (vitamin A/retinoid pathway) variants. STRA6 defects disrupt retinoic acid signaling critical for eye and craniofacial patterning. ScienceDirect

6. HCCS (MLS syndrome). Microphthalmia with linear skin defects; some cases include craniofacial anomalies. NCBI

7. BMP4/SMOC1 and other eye-patterning gene variants. These are part of the genetic network shaping the early optic cup and facial prominences. ScienceDirect

8. PAX6 variants. Classic eye development gene; variants can contribute to A/M or coloboma and may co-occur with craniofacial anomalies. SpringerLink

9. CHD7 (CHARGE syndrome). Midline facial growth and multiple organ systems can be affected, with coloboma and clefts in some children. SpringerLink

10. TFAP2A (branchio-oculo-facial syndrome). Can link eye malformations with cleft lip/palate and distinctive facial features. SpringerLink

11. Chromosomal copy-number changes (microdeletions/duplications) that disrupt A/M genes (e.g., deletions involving SOX2/OTX2). PMC

12. Congenital viral infections (TORCH group—CMV, rubella, toxoplasmosis, etc.). These can injure developing retina and brain, and are associated with eye malformations and clefts in some studies. NCBI+2Obstetrics & Gynecology+2

13. Zika and other emerging congenital infections. Early-pregnancy infection can disrupt eye and facial development. RSNA Publications+1

14. Maternal retinoid exposure (e.g., isotretinoin). Causes the fetal retinoid syndrome pattern—craniofacial malformations including cleft palate and eye anomalies. New England Journal of Medicine+1

15. Other teratogenic medications/chemicals (e.g., thalidomide). Historical and modern reviews list microphthalmia and clefts among potential outcomes. Frontiers+1

16. Maternal diabetes (especially pre-gestational). Strongly linked to a range of birth defects, including orofacial clefts. PLOS+1

17. High maternal fever/hyperthermia in very early pregnancy. Animal and human data suggest increased risk of facial clefts (though human studies are mixed). Wiley Online Library+1

18. Nutritional retinoid imbalance (severe deficiency or excess). Retinoic acid signaling is crucial for midface and eye patterning; experimental and epidemiologic data implicate imbalance. SAGE Journals+1

19. Polygenic and multifactorial influences. Many cases likely reflect combined genetic susceptibilities plus environmental exposures. SpringerLink

20. Syndromic chromosomal disorders (e.g., trisomy 13). Pleiotropic conditions can include microphthalmia and cleft lip/palate among multiple anomalies. (General A/M and associated anomaly datasets support this clustering.) ScienceDirect

Symptoms and signs

1. Obvious small eye(s) or a small eye socket—the eye fissure may look narrow; sometimes the eyeball is hard to see. A bright-light red reflex can be dull, asymmetric, or absent. PMC
2. Very reduced vision or blindness in the affected eye(s). Severity depends on how under-developed the eye structures are. JAMA Network
3. Nystagmus (shaky eye movements) from very poor retinal input early in life. PMC
4. Strabismus (eye misalignment), often noticeable as the child tries to fixate—checked with a simple penlight Hirschberg test. Cleveland Clinic
5. Coloboma (a keyhole-like gap in the iris, retina, or optic nerve) sometimes co-exists with microphthalmia. Orpha
6. Cataract (lens clouding) or microcornea (very small cornea), which further reduce visual clarity. WebEye
7. Ptosis (droopy lid) or eyelid abnormalities due to shallow orbit or associated craniofacial differences. PMC
8.  Facial cleft features—cleft lip with or without cleft palate; sometimes oblique facial clefts that extend toward the inner eye corner. CDC+1
9.  Feeding and speech difficulties in babies with cleft palate (nasal regurgitation, later speech resonance issues). Mayo Clinic
10.  Recurrent ear infections or hearing loss (common in cleft palate and in some syndromic forms of A/M). Ajo
11. Developmental delay or learning problems in some genetic forms (e.g., SOX2, OTX2), sometimes with seizures. NCBI+1
12. Endocrine issues (e.g., pituitary hypoplasia in OTX2-related disease), which may affect growth or puberty. Oxford Academic
13. Associated brain and heart differences in syndromic cases; clinicians often screen because these clusters are more frequent with A/M. ScienceDirect
14. Dental and jaw alignment problems (cleft-related), affecting bite and facial growth over time. Children’s Hospital of Philadelphia
15. Psychosocial impact from visible differences in face and eyes; early multidisciplinary support is recommended. Nature

Diagnostic tests

Doctors combine history, examination, imaging, electrodiagnostic studies, and genetic/lab tests to confirm the diagnosis, understand severity, and plan care. Below are 20 commonly used tests, grouped by type, with a short, plain reason for each.

A) Physical examination (bedside)

1. Newborn eye inspection with red-reflex test. A simple dark-room torch exam; an absent or asymmetric red reflex suggests media opacity or a very small/abnormal eye and needs urgent specialist review. PMC+1

2. General craniofacial exam noting cleft lip/palate or oblique (Tessier) clefts, nasal asymmetry, and eyelid margin anomalies—key for classifying the cleft. Radiopaedia

3. Ocular alignment check (Hirschberg penlight test). Quick screen for strabismus that often accompanies poor vision in microphthalmia. Cleveland Clinic

4. Corneal diameter measurement (ruler or calipers). Microcornea (< ~9–10 mm in newborns) suggests globe hypoplasia and informs surgical/device choices. WebEye+1

5. Craniofacial anthropometry (intercanthal/interorbital distances, palpebral fissure length, philtrum). Helps document facial growth and surgical planning. AJNR

B) “Manual/office” ophthalmic tests (non-lab, non-imaging)

6. Axial length measurement (A-scan biometry). Microphthalmia is typically defined by very short axial length for age (e.g., <19 mm at ~1 year). gene.vision+1

7. Handheld slit-lamp / anterior segment exam (often during exam under anesthesia). Documents microcornea, cataract, adhesions, or persistent fetal vasculature. PMC

8. Handheld OCT (optical coherence tomography) when feasible. Non-invasive imaging of retina/optic nerve helps judge visual potential in infants. PMC+1

9. Refraction and visual-behavior assessment. Determines any correctable refractive error and the level of functional vision for therapy planning. Nature

10. Socket/orbital soft-tissue assessment by oculoplastics to plan expanders or prostheses in severe microphthalmia/anophthalmia. Nature

C) Laboratory & pathological / genetic testing

11. Chromosomal microarray to look for copy-number changes involving A/M genes (e.g., deletions around SOX2, OTX2). Guides counseling. PMC

12. Targeted multigene panel or exome sequencing for A/M (SOX2, OTX2, BCOR, ALX1, STRA6, CHD7, TFAP2A, etc.). High yield in syndromic cases. SpringerLink+1

13. TORCH testing (maternal/infant serology or PCR) if congenital infection is suspected (CMV, toxoplasma, rubella, syphilis, varicella, Zika as regionally indicated). Obstetrics & Gynecology+1

14. Systemic work-up tailored to the gene/syndrome (e.g., pituitary hormones in OTX2, hearing studies in CHARGE, cardiac screening as indicated). Oxford Academic+1

D) Electrodiagnostic tests (objective vision tests)

15. Electroretinogram (ERG). Measures retinal function; helps distinguish retinal from brain or nerve-level problems when the eye is small or media are cloudy. PubMed

16. Visual evoked potential (VEP). Confirms whether any visual signal reaches the brain in apparent anophthalmia/severe microphthalmia and can estimate acuity. Nature+2Nature+2

E) Imaging tests

17. Prenatal ultrasound (2D/3D) of face and orbits. Many cleft lips are detected around 18–22 weeks; cleft palate alone is harder to see. Dedicated views improve detection. PMC+2PMC+2

18. Fetal MRI if ultrasound suggests microphthalmia/anophthalmia or complex clefting. Clarifies eye tissue, optic nerves, and brain structures. PMC

19. Postnatal B-scan ocular ultrasound. Visualizes a very small or opaque eye, lens remnants, vitreous, and retina to guide expectations and surgery. ResearchGate

20. Orbital/craniofacial CT or MRI (postnatal). Defines the bony orbit and cleft pathways for surgical planning; 3-D CT is often used for Tessier clefts. Plastic Surgery Key

Non-pharmacological treatments

1. Early referral to a cleft–craniofacial & ophthalmic team: Coordinates surgeries, eye care, speech, hearing, and growth from infancy. Purpose: organize staged care. Mechanism: multidisciplinary protocols improve feeding, speech, socket growth, and psychosocial outcomes. ASHA+1

2. Feeding support and special bottles: Trained feeding methods and cleft-adapted bottles reduce choking and help weight gain. Purpose: safe nutrition before palate repair. Mechanism: controlled flow compensates for poor suction. ASHA

3. Speech-language therapy: Begins early and continues after palate repair. Purpose: clear speech and correct resonance. Mechanism: exercises and targeted therapy build articulation and velopharyngeal function. ASHA

4. Amblyopia therapy (if any vision): Patching the better eye and using glasses to stimulate the weaker eye. Purpose: protect and maximize vision. Mechanism: neuroplasticity of visual cortex in early childhood. MedlinePlus

5. Protective eyewear and sun care: Safety glasses and hats protect the seeing eye and sensitive lids. Purpose: prevent injuries and photophobia. Mechanism: reduces UV/trauma risks. MedlinePlus

6. Ocular surface care (non-drug steps): Humidifiers, lid hygiene, and frequent breaks. Purpose: comfort if lids are short or exposure exists. Mechanism: lowers evaporation/irritants. MedlinePlus

7. Conformers (socket expanders): Series of custom shapes in the socket to gently stretch soft tissues. Purpose: help the orbit and eyelids grow more symmetrically. Mechanism: gradual volume expansion triggers tissue remodeling. PubMed

8. Hydrogel/implant orbital expanders (selected cases): When more volume is needed than conformers alone. Purpose: stimulate bony/soft-tissue orbital growth. Mechanism: space-occupying implants promote growth by pressure/volume. ResearchGate

9. Artificial eye (prosthesis) fitting: Improves cosmesis and supports lid/fornix shape. Purpose: symmetry and social confidence. Mechanism: prosthesis maintains socket volume and eyelid position. ResearchGate

10. Occupational therapy & low-vision rehab: Teaches lighting, contrast, and orientation skills. Purpose: independence. Mechanism: compensatory strategies and devices maximize remaining vision. MedlinePlus

11. Hearing care (ear tubes when indicated) & audiology: Purpose: prevent speech/language delay from middle-ear fluid. Mechanism: ventilation tubes reduce effusions. ASHA

12. Orthodontics and dentofacial orthopedics: Purpose: align teeth/jaw and prepare for alveolar bone grafts if needed. Mechanism: phased appliances and growth guidance. AAPD

13. Psychological support & peer groups: Purpose: coping, self-image, family resilience. Mechanism: counseling and support networks reduce distress. ASHA

14. Nutrition counseling in infancy/pregnancy: Purpose: safe growth for baby; future pregnancies with folate guidance. Mechanism: tailored diet, folic acid per public-health advice. CDC Stacks

15. Early-intervention education services: Purpose: developmental support. Mechanism: therapy plans for motor, vision, speech. ASHA

16. Home eye safety planning: remove hazards; teach one-eyed safety rules. Purpose: protect the better-seeing eye. Mechanism: risk reduction. MedlinePlus

17. UV protection for lids/skin: hats, shade, sunscreen near prosthesis area. Purpose: comfort and skin health. Mechanism: reduces inflammation/UV damage. MedlinePlus

18. Cleft team dental hygiene program: fluoride, sealants, and regular visits. Purpose: prevent caries in altered anatomy. Mechanism: protective coatings and coaching. AAPD

19. Caregiver training for conformer/prosthesis handling: Purpose: safe insertion/removal and cleaning. Mechanism: reduces infection and irritation. ResearchGate

20. Genetic counseling: explains recurrence risk, testing options, and pregnancy planning. Purpose: informed choices. Mechanism: interprets panels/CMA/exome results. MedlinePlus

---

Drug treatments

Important: There is no medicine that makes a missing or small eye “grow back.” Medicines are used to protect the surface, treat infections or glaucoma, control inflammation, treat reflux/ear issues around palate care, and manage post-surgical pain. Doses must be individualized by the child’s doctors.

1. Preservative-free lubricating eye drops/gel
   Class: ocular lubricants. Dose/time: drops or gel several times daily as needed. Purpose: relieve dryness from exposure or eyelid gaps. Mechanism: adds a tear layer to protect the cornea. Side effects: brief blur, rare irritation. MedlinePlus

2. Lubricating ointment at bedtime
   Class: ocular ointment. Dose/time: thin ribbon at night. Purpose: overnight protection if lids don’t close fully. Mechanism: long-lasting barrier. Side effects: morning blur/grease. MedlinePlus

3. Topical antibiotic drops/ointment (short course when infected)
   Class: ophthalmic antibiotics. Dose/time: per culture/doctor (e.g., 4×/day for 5–7 days). Purpose: treat bacterial conjunctivitis or prosthesis-related infection. Mechanism: kills bacteria. Side effects: irritation, rare allergy. MedlinePlus

4. Topical steroid drops (short, supervised courses)
   Class: corticosteroids. Dose/time: tapered course for significant inflammation. Purpose: calm severe surface inflammation after surgery or irritation. Mechanism: blocks inflammatory pathways. Side effects: pressure rise (glaucoma), infection risk — must be monitored. MedlinePlus

5. Topical antibiotic–steroid combination
   Class: combo drops/ointments. Use: selected post-op eyelid procedures or inflamed, infected lids. Mechanism: antimicrobial + anti-inflammatory. Risks: pressure rise, delayed healing — short and supervised only. MedlinePlus

6. Antiviral therapy (e.g., for neonatal herpes eye disease when present)
   Class: ocular/systemic antivirals. Use: only if a proven viral infection threatens the eye. Mechanism: blocks viral replication. Side effects: vary by drug. MedlinePlus

7. Antiglaucoma eye drops (if secondary glaucoma is diagnosed)
   Class: beta-blockers, carbonic-anhydrase inhibitors, others. Purpose: lower eye pressure to protect the optic nerve. Mechanism: reduce aqueous production/increase outflow. Side effects: local irritation; systemic effects in infants require careful pediatric dosing. MedlinePlus

8. Cycloplegic drops (e.g., atropine for amblyopia therapy)
   Class: anticholinergic. Dose/time: per pediatric ophthalmology protocol. Purpose: blur the strong eye to force use of the weak eye when patching fails. Mechanism: paralyzes accommodation and dilates pupil. Side effects: light sensitivity, systemic anticholinergic effects (rare). MedlinePlus

9. Allergy drops (antihistamine/mast-cell stabilizers)
   Class: anti-allergic. Purpose: reduce itch/rub that can injure the surface. Mechanism: blocks histamine and mast-cell release. Side effects: sting, rare headache. MedlinePlus

10. Pain control after lip/palate surgery (acetaminophen ± ibuprofen as directed)
    Class: analgesics/NSAIDs. Purpose: comfort and quicker recovery. Mechanism: central COX inhibition (acetaminophen), COX blockade (NSAIDs). Side effects: liver risk with overdose (acetaminophen), stomach/kidney risks (NSAIDs). Follow surgeon’s plan. ACPA

11. Antibiotics around cleft or ocular surgery when indicated
    Class: systemic antibiotics. Purpose: infection prophylaxis/treatment when risk is high. Mechanism: pathogen-specific. Side effects: diarrhea, allergy. ACPA

12. Reflux medicines when feeding problems cause aspiration
    Class: acid suppression or alginates as indicated. Purpose: protect airway and growth. Mechanism: reduces acid or reflux events. Side effects: vary; use only if clearly needed. ASHA

13. Iron/vitamin D per pediatric guidance
    Class: supplements. Purpose: correct common infant deficiencies that can slow growth and recovery. Mechanism: supports hematologic and bone health. Side effects: GI upset with iron. ASHA

14. Saline nasal sprays/gel after lip/palate procedures
    Class: topical saline. Purpose: ease crusting and nasal dryness. Mechanism: humidifies mucosa. Side effects: minimal. ACPA

15. Otitis media prevention/treatment meds
    Class: as per pediatric ENT (topicals/systemics). Purpose: protect hearing to support speech. Mechanism: treat infection/inflammation. Side effects: drug-specific. ASHA

16. Topical antibiotic cover with conformer changes (short course if needed)
    Class: ophthalmic antibiotics. Purpose: reduce infection risk when there’s irritation or abrasion. Mechanism: bactericidal/static. Side effects: local irritation. ResearchGate

17. Artificial tears for the seeing eye (lifelong habit)
    Class: lubricants. Purpose: protect the “good” eye from overuse dryness. Mechanism: tear film support. Side effects: mild blur. MedlinePlus

18. Antibiotic-steroid lid ointments for eyelid coloboma post-repair (short course)
    Class: combo topical. Purpose: reduce inflammation/infection as incision heals. Mechanism: antimicrobial + anti-inflammatory. Risks: short supervised use only. MedlinePlus

19. Topical cyclosporine for chronic surface inflammation (selected older children)
    Class: calcineurin inhibitor. Purpose: steroid-sparing control of keratoconjunctivitis. Mechanism: reduces T-cell–mediated inflammation. Side effects: sting/burn. Specialist use. MedlinePlus

20. Vaccinations (general pediatric schedule)
    Class: immunizations. Purpose: prevent infections that could complicate surgeries and health. Mechanism: adaptive immunity. Side effects: routine vaccine reactions. Follow national schedule. CDC

---

Dietary molecular supplements

Note: Supplements do not reverse microphthalmia or clefts. They support general growth or pregnancy planning. Always follow pediatric/obstetric advice.

1. Folic acid (for future pregnancy planning) — Typical public-health dose: 400 µg/day for people who could become pregnant, begun at least 1 month before conception and during early pregnancy; higher doses only when a clinician advises it. Supports neural-tube and possibly lip/palate closure pathways; evidence for cleft prevention is mixed but leans helpful, and it is strongly recommended for NTD prevention. CDC+2CDC Stacks+2

2. Prenatal multivitamin — Provides balanced micronutrients (iodine, iron, B-complex) that support fetal development. Dose: as labeled for pregnancy. Mechanism: fills common dietary gaps. CDC

3. Vitamin B12 (if deficient) — Dose: per labs/doctor. Mechanism: DNA synthesis; partners with folate. CDC

4. Docosahexaenoic acid (DHA) — Dose: typical prenatal DHA 200–300 mg/day. Mechanism: supports neuro-retinal development and general infant health; does not treat the malformation. MedlinePlus

5. Vitamin D (per pediatric targets) — Dose: common infant 400 IU/day unless otherwise directed. Mechanism: bone and immune support. ASHA

6. Iron (if low) — Dose: individualized after labs. Mechanism: prevents anemia; supports growth and healing. ASHA

7. Calcium (diet-first) — Mechanism: skeletal growth, especially with orthodontic phases. Dose: per age recommendations. AAPD

8. Iodine (as part of prenatal vitamin) — Mechanism: thyroid hormone production essential for brain growth. Dose: per prenatal label. CDC

9. Zinc (if deficient) — Mechanism: tissue repair and immune function. Dose: clinician-guided. CDC

10. Fiber and hydration (food-first) — Mechanism: reduces post-op constipation from pain meds and supports feeding comfort. Dose: dietitian-guided. ASHA

---

Immunity booster / regenerative / stem-cell drugs

Transparent note: There are no approved “stem-cell drugs” or regenerative medicines that restore a congenitally absent/small eye or close a congenital cleft. Research exists in ocular tissue engineering (e.g., limbal stem cells for corneal disease) but that is not a treatment for congenital microphthalmia. Safer, evidence-based actions include vaccines and nutrition.

1. Routine childhood vaccinations — protect against infections that could complicate surgeries or recovery. Dose/timing: national schedule. CDC

2. Influenza vaccine (annual) — reduces winter respiratory infections before/after surgeries. CDC

3. Maternal rubella vaccination before pregnancy — prevents congenital rubella syndrome. Timing: pre-conception. CDC

4. Good nutrition (protein, iron, vitamins) instead of “booster” pills — supports wound healing and growth. ASHA

5. Experimental ocular tissue engineering — research only; not a standard therapy for A/M. Families should avoid clinics advertising cures. MedlinePlus

6. Genetic counseling and future-pregnancy planning — not a drug, but the most effective “preventive” step after a genetic diagnosis. MedlinePlus

---

Surgeries

1. Cleft lip repair — closes the lip gap, usually in the first months of life. Why: improves feeding, nasal form, and symmetry; first step in staged cleft care. ACPA

2. Cleft palate repair — closes the palate typically around 6–12 months (varies by center and child). Why: enables normal speech development and reduces ear problems. ASHA+1

3. Alveolar bone grafting with orthodontic phases — adds bone to the gum ridge later in childhood. Why: supports teeth eruption and stabilizes the dental arch. AAPD

4. Orbital socket expansion (conformers, hydrogel expanders, or box osteotomy in complex cases) — staged volume expansion; occasionally bony surgery for orbit shape/position. Why: promote facial symmetry and allow prosthesis fitting. PubMed+2ResearchGate+2

5. Eyelid repairs (e.g., coloboma closure, ptosis surgery) and strabismus surgery — tailored to protect the cornea and improve alignment. Why: eye-surface safety, cosmesis, and function. MedlinePlus

---

Prevention

1. Take folic acid 400 µg/day if you could become pregnant; start before conception. CDC

2. Avoid isotretinoin/retinoids in pregnancy; use effective contraception if on these medicines. ResearchGate

3. Vaccinate against rubella before pregnancy (if not immune). CDC

4. Manage diabetes well before and during early pregnancy. CDC

5. Avoid alcohol, tobacco, and illicit drugs in pregnancy. CDC

6. Prevent infections (hand hygiene, safe foods, CMV precautions). CDC

7. Review all medicines with your doctor before conception. CDC

8. Healthy prenatal diet with prenatal vitamins as advised. CDC

9. Early prenatal care and ultrasound follow-up if anything looks unusual. CDC

10. Genetic counseling if there is family history or a prior affected child. MedlinePlus

---

When to see doctors

• Immediately in newborns: visible cleft, feeding trouble, choking, poor weight gain, or obvious small/absent eye. Early team referral is key. ASHA

• Urgent eye care: red/painful eye, discharge, light sensitivity, eyelid not closing, or prosthesis not fitting. MedlinePlus

• Hearing/speech concerns: persistent ear fluid, delayed babbling/words. ASHA

• Developmental concerns or seizures (if syndromic features suspected). MedlinePlus

• Planning another pregnancy: ask for genetics and folate advice. CDC

---

What to eat and what to avoid

1. Eat folate-rich foods (lentils, beans, leafy greens) and take folic acid as advised if planning pregnancy. CDC

2. Adequate protein (eggs, fish, legumes) for wound healing after surgeries. ASHA

3. Iron-rich foods (meat/beans) and vitamin-C fruits to help absorption. ASHA

4. DHA sources (low-mercury fish) or prenatal DHA if recommended. MedlinePlus

5. Hydration and fiber to prevent constipation during post-op recovery. ASHA

6. Avoid high-vitamin-A retinoid supplements unless prescribed; balanced dietary vitamin A is fine. ResearchGate

7. Avoid alcohol and avoid tobacco in pregnancy. CDC

8. Food safety (avoid unpasteurized dairy, undercooked meats) to reduce infection risk in pregnancy. CDC

9. Limit sugary drinks to protect teeth around orthodontic care. AAPD

10. Use pediatric dietitian input for infants with cleft feeding issues. ASHA

---

FAQs

1. Can medicine make the small or missing eye normal?
   No. Medicines help comfort and protection; surgery and prosthetics address appearance and function. MedlinePlus

2. Is vision always lost?
   Not always. Some microphthalmic eyes see; careful testing and amblyopia therapy can help. MedlinePlus

3. When are cleft surgeries done?
   Lip in the first months; palate often around 6–12 months (varies by center/child). ACPA+1

4. Do conformers really grow the socket?
   They provide volume that encourages soft-tissue and bony growth, improving symmetry over time. PubMed

5. What is an orbital cyst, and is it bad?
   A development cyst can accompany A/M; sometimes it’s left to support growth, sometimes removed if it distorts lids — individualized. PubMed

6. Should we do genetic testing?
   Yes, panels/CMA/exome can find causes and guide counseling, though many cases remain unsolved. Nature

7. Will my next baby have the same problem?
   Risk depends on the cause; genetic counseling clarifies recurrence chances. MedlinePlus

8. Does folic acid prevent clefts?
   Evidence is mixed for clefts but strong for neural-tube defects; it is still recommended for all who could become pregnant. CDC+2CDC Stacks+2

9. Are “stem-cell cures” available?
   No approved therapy restores a missing/small eye; avoid unproven clinics. MedlinePlus

10. Will my child need speech therapy?
    Usually yes, especially with palate involvement, to build clear speech. ASHA

11. What about hearing?
    Cleft palate raises middle-ear fluid risk; ENT care and possible ear tubes help. ASHA

12. Is school participation normal?
    With team care, children usually attend regular school; accommodations for low vision or speech may help. ASHA

13. How do we protect the better-seeing eye?
    Use protective eyewear, UV hats, and safety plans at home/school. MedlinePlus

14. Do we need orthodontics?
    Often yes; orthodontics plus bone grafting can support teeth and jaw growth. AAPD

15. Where can families find reliable guidance?
    Cleft and craniofacial teams and pediatric ophthalmology services; national groups like ACPA provide family handbooks. ACPA

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: September 19, 2025.